Impact of Clinical Pharmacist on the Quality and Cost of the Therapeutic Management of Patients in Two Medical Services of a Teaching Hospital

Not Applicable

Completed

• Conditions: Admitted to Infectiology or Internal Medicine Wards
• Interventions: Other: Pharmacist consultation

• Registration Number: NCT02887001
• Lead Sponsor: Centre Hospitalier Universitaire de Nīmes

Brief Summary

Incomplete information or poorly communicated to the transitional stages of the patient's drug therapy hospitalized cause medication errors. These steps are the admission, transfer within the institution and hospital discharge to home or another institution.

The adequacy of the prescription recommendations of good practice is not always optimal.

The cost of taking drug therapy and iatrogenic risks preventable drug-related weighs more and more heavily in health spending and in the prolongation of hospitalization or re hospitalization.

Clinical pharmacy widely practiced in the Anglo-Saxon countries has demonstrated its effectiveness on these three themes; it seems appropriate to assess this practice in the environment of the French health system.

Detailed Description

Not available

Study Timeline

• Study Start: 2011-06
• Primary Completion: 2012-07
• Status Verified: 2016-07
• Study First Submitted: 2016-08-24
• Study First Submitted QC: 2016-08-29
• Last Update Submitted: 2016-08-29
• Study First Posted: 2016-09-01
• Last Update Posted: 2016-09-01

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: 500

Inclusion Criteria

• patients admitted in in infectious and tropical diseases unit or the internal medicine unit

Exclusion Criteria

• none

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: SINGLE_GROUP

Arm && Interventions

Group	Intervention	Description
BMO	Pharmacist consultation	-

Primary Outcome Measures

Name	Time	Method
Number of prescriptions	11 weeks